JCIC Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
JCIC Asset Management's NVO Position: Q3 2026 in Review
JCIC Asset Management increased its Novo Nordisk (NVO) stake by 30% in Q3 2026, buying an estimated $774K and bringing the position to 72,923 shares worth $2.76M. The position accounts for 1.13% of the portfolio, ranked #26.
JCIC Asset Management first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.19M in Q2 2024. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- JCIC Asset Management held 72,923 shares of Novo Nordisk worth $2.76M as of Q3 2026.
- JCIC Asset Management bought 16,784 Novo Nordisk shares in Q3 2026, an estimated $774K.
- Novo Nordisk made up 1.13% of JCIC Asset Management's portfolio in Q3 2026, its #26 holding.
- JCIC Asset Management first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
- JCIC Asset Management's Novo Nordisk position peaked at $5.19M in Q2 2024.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on JCIC Asset Management's 13F filing for Q3 2026, filed 30 Oct 2026.